Skip to content
PubMed This is a summary of 53 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 53 referenced papers

Top Authors

Peter J. Goadsby
University College London
Bryan L. Roth
Case Western Reserve University
Arne May
National Hospital for Neurology and Neurosurgery
David E. Olson
Multidisciplinary Association for Psychedelic Studies
Roland R. Griffiths
Johns Hopkins Medicine
Robin Carhart‐Harris
Imperial College London
David E. Nichols
Purdue University West Lafayette
Messoud Ashina
Rigshospitalet
Mads Barloese
Copenhagen University Hospital
Rigmor Jensen
University of Copenhagen

Top Institutions

Ranked by publications Top 10 institutions
03

Institute for Health Metrics and Evaluation

Seattle, United States

5 papers

References

References (53)
  1. 1

    Cardiac monitoring of high-dose verapamil in cluster headache: An international Delphi study.

    Koppen H, Stolwijk J, Wilms EB, et al.

    Cephalalgia : an international journal of headache 2016; (36(14)):1385-1388 doi:10.1177/0333102416631968.

    PMID: 26868817
  2. 2

    The anterior hypothalamus in cluster headache.

    Arkink EB, Schmitz N, Schoonman GG, et al.

    Cephalalgia : an international journal of headache 2017; (37(11)):1039-1050 doi:10.1177/0333102416660550.

    PMID: 27530226
  3. 3

    Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.

    Cady RK, Munjal S, Cady RJ, et al.

    The journal of headache and pain 2017; (18(1)):17 doi:10.1186/s10194-016-0717-7.

    PMID: 28176235
  4. 4

    Endodontic Board Certification: A Review of Factors Affecting the Certification Rate.

    Case E, Williamson A, Johnson WT, et al.

    Journal of endodontics 2017; (43(8)):1255-1261 doi:10.1016/j.joen.2017.03.022.

    PMID: 28578885
  5. 5

    Prescribing Oxygen for Cluster Headache: A Guide for the Provider.

    Tepper SJ, Duplin J, Nye B, Tepper DE

    Headache 2017; (57(9)):1428-1430 doi:10.1111/head.13180.

    PMID: 28857152
  6. 6

    Cluster headache.

    May A, Schwedt TJ, Magis D, et al.

    Nature reviews. Disease primers 2018; (4()):18006 doi:10.1038/nrdp.2018.6.

    PMID: 29493566
  7. 7

    If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients' own stories of their experiences.

    Rossi P, Little P, De La Torre ER, Palmaro A

    Functional neurology 2018; (33(1)):57-59 doi:10.11138/fneur/2018.33.1.057.

    PMID: 29633698
  8. 8

    High dosage of methylprednisolone in cluster headache.

    D'Arrigo G, Di Fiore P, Galli A, Frediani F

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2018; (39(Suppl 1)):157-158 doi:10.1007/s10072-018-3383-5.

    PMID: 29904864
  9. 9

    Increased suicidality in patients with cluster headache.

    Ji Lee M, Cho SJ, Wook Park J, et al.

    Cephalalgia : an international journal of headache 2019; (39(10)):1249-1256 doi:10.1177/0333102419845660.

    PMID: 31018651
  10. 10

    Trial of Galcanezumab in Prevention of Episodic Cluster Headache.

    Goadsby PJ, Dodick DW, Leone M, et al.

    The New England journal of medicine 2019; (381(2)):132-141 doi:10.1056/NEJMoa1813440.

    PMID: 31291515
  11. 11

    Interictal Burden of Cluster Headache: Results of the EUROLIGHT Cluster Headache Project, an Internet-Based, Cross-Sectional Study of People With Cluster Headache.

    Pohl H, Gantenbein AR, Sandor PS, et al.

    Headache 2020; (60(2)):360-369 doi:10.1111/head.13711.

    PMID: 31762031
  12. 12

    Ultra-rapid brain uptake of subcutaneous sumatriptan in the rat: Implication for cluster headache treatment.

    Muzzi M, Zecchi R, Ranieri G, et al.

    Cephalalgia : an international journal of headache 2020; (40(4)):330-336 doi:10.1177/0333102419896370.

    PMID: 31852231
  13. 13

    Disability, Quality of Life, and Socioeconomic Burden of Cluster Headache: A Critical Review of Current Evidence and Future Perspectives.

    D'Amico D, Raggi A, Grazzi L, Lambru G

    Headache 2020; (60(4)):809-818 doi:10.1111/head.13784.

    PMID: 32108941
  14. 14

    Evolving options for the treatment of cluster headache.

    Villar-Martinez MD, Chan C, Goadsby PJ

    Current opinion in neurology 2020; (33(3)):323-328 doi:10.1097/WCO.0000000000000808.

    PMID: 32209808
  15. 15

    Perceptions, experiences, and understandings of cluster headache among GPs and neurologists: a qualitative study.

    Buture A, Ahmed F, Mehta Y, et al.

    The British journal of general practice : the journal of the Royal College of General Practitioners 2020; (70(696)):e514-e522 doi:10.3399/bjgp20X710417.

    PMID: 32482627
  16. 16

    Medication overuse headache: Divergent effects of new acute antimigraine drugs.

    Holland PR, Saengjaroentham C, Sureda-Gibert P, Strother LC

    Cephalalgia : an international journal of headache 2020; (40(9)):889-891 doi:10.1177/0333102420938655.

    PMID: 32615789
  17. 17

    The state of the headache fellowship application process and attitudes toward the match.

    Zhang N, Armand C, Berk T, Friedman DI

    Neurology 2020; (95(10)):e1294-e1300 doi:10.1212/WNL.0000000000010186.

    PMID: 32631925
  18. 18

    Cluster headache and TACs: state of the art.

    Giani L, Proietti Cecchini A, Leone M

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2020; (41(Suppl 2)):367-375 doi:10.1007/s10072-020-04639-4.

    PMID: 32845489
  19. 19

    Cluster Headache: Opportunities for Pharmacists to Improve Care.

    Wenzel R, Smith TR, Clark AS

    Journal of pharmacy practice 2022; (35(2)):281-288 doi:10.1177/0897190020964297.

    PMID: 33034236
  20. 20

    Real-life treatment of cluster headache in a tertiary headache center - results from the Danish Cluster Headache Survey.

    Petersen AS, Lund N, Jensen RH, Barloese M

    Cephalalgia : an international journal of headache 2021; (41(5)):525-534 doi:10.1177/0333102420970455.

    PMID: 33203216
  21. 21

    Cluster headache is one of the most intensely painful human conditions: Results from the International Cluster Headache Questionnaire.

    Burish MJ, Pearson SM, Shapiro RE, et al.

    Headache 2021; (61(1)):117-124 doi:10.1111/head.14021.

    PMID: 33337540
  22. 22

    Cluster headache pathophysiology - insights from current and emerging treatments.

    Wei DY, Goadsby PJ

    Nature reviews. Neurology 2021; (17(5)):308-324 doi:10.1038/s41582-021-00477-w.

    PMID: 33782592
  23. 23

    Demoralization predicts suicidality in patients with cluster headache.

    Koo BB, Bayoumi A, Albanna A, et al.

    The journal of headache and pain 2021; (22(1)):28 doi:10.1186/s10194-021-01241-7.

    PMID: 33879041
  24. 24

    [Sumatriptan 3 mg subcutaneous : Clinical relevance of acute treatment of migraine despite dose reduction].

    Gaul C, Förderreuther S

    Der Nervenarzt 2022; (93(6)):612-617 doi:10.1007/s00115-021-01189-8.

    PMID: 34557933
  25. 25

    Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study.

    Merli E, Asioli GM, Favoni V, et al.

    Journal of neurology 2022; (269(4)):2193-2199 doi:10.1007/s00415-021-10884-0.

    PMID: 34820736
  26. 26

    Cluster headache in adults.

    Ray JC, Stark RJ, Hutton EJ

    Australian prescriber 2022; (45(1)):15-20 doi:10.18773/austprescr.2022.004.

    PMID: 35233134
  27. 27

    Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists.

    Goldman RE, Damush TM, Kuruvilla DE, et al.

    Headache 2022; (62(3)):306-318 doi:10.1111/head.14277.

    PMID: 35293614
  28. 28

    Recent advances in the diagnosis and management of cluster headache.

    Schindler EAD, Burish MJ

    BMJ (Clinical research ed.) 2022; (376()):e059577 doi:10.1136/bmj-2020-059577.

    PMID: 35296510
  29. 29

    The promises and perils of psychedelic pharmacology for psychiatry.

    McClure-Begley TD, Roth BL

    Nature reviews. Drug discovery 2022; (21(6)):463-473 doi:10.1038/s41573-022-00421-7.

    PMID: 35301459
  30. 30

    Network meta-analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster.

    Medrea I, Christie S, Tepper SJ, et al.

    Headache 2022; (62(4)):482-511 doi:10.1111/head.14283.

    PMID: 35343597
  31. 31

    Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol.

    Davide M, Giacomo U, Maria AG, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(9)):5777-5778 doi:10.1007/s10072-022-06198-2.

    PMID: 35750950
  32. 32

    Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.

    Schindler EAD, Sewell RA, Gottschalk CH, et al.

    Headache 2022; (62(10)):1383-1394 doi:10.1111/head.14420.

    PMID: 36416492
  33. 33

    Debate: Are cluster headache and migraine distinct headache disorders?

    Al-Karagholi MA, Peng KP, Petersen AS, et al.

    The journal of headache and pain 2022; (23(1)):151 doi:10.1186/s10194-022-01504-x.

    PMID: 36447146
  34. 34

    Are psychedelics the answer to chronic pain: A review of current literature.

    Kooijman NI, Willegers T, Reuser A, et al.

    Pain practice : the official journal of World Institute of Pain 2023; (23(4)):447-458 doi:10.1111/papr.13203.

    PMID: 36597700
  35. 35

    Cranial Autonomic Symptoms and Neck Pain in Differential Diagnosis of Migraine.

    Vicente BN, Oliveira R, Martins IP, Gil-Gouveia R

    Diagnostics (Basel, Switzerland) 2023; (13(4)) doi:10.3390/diagnostics13040590.

    PMID: 36832077
  36. 36

    A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.

    Lewis V, Bonniwell EM, Lanham JK, et al.

    Cell reports 2023; (42(3)):112203 doi:10.1016/j.celrep.2023.112203.

    PMID: 36884348
  37. 37

    European Academy of Neurology guidelines on the treatment of cluster headache.

    May A, Evers S, Goadsby PJ, et al.

    European journal of neurology 2023; (30(10)):2955-2979 doi:10.1111/ene.15956.

    PMID: 37515405
  38. 38

    The Prevalence and Clinical Phenotypes of Cluster Headache in Relation with Latitude.

    Liaw YC, Chen SP, Wang SJ

    Current pain and headache reports 2024; (28(5)):427-438 doi:10.1007/s11916-024-01229-3.

    PMID: 38441794
  39. 39

    Oxygen as an abortive therapy in cluster headache: a narrative review and clinical practice aspects.

    Van Houtte J, Vandenbussche N, Derom E, et al.

    Acta neurologica Belgica 2024; (124(4)):1225-1231 doi:10.1007/s13760-024-02506-z.

    PMID: 38498266
  40. 40

    Cluster headache: an update on clinical features, epidemiology, pathophysiology, diagnosis, and treatment.

    San-Juan D, Velez-Jimenez K, Hoffmann J, et al.

    Frontiers in pain research (Lausanne, Switzerland) 2024; (5()):1373528 doi:10.3389/fpain.2024.1373528.

    PMID: 38524268
  41. 41

    Cluster Headache, SUNCT, and SUNA.

    Burish M

    Continuum (Minneapolis, Minn.) 2024; (30(2)):391-410 doi:10.1212/CON.0000000000001411.

    PMID: 38568490
  42. 42

    Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.

    Schindler EAD, Sewell RA, Gottschalk CH, et al.

    Journal of the neurological sciences 2024; (460()):122993 doi:10.1016/j.jns.2024.122993.

    PMID: 38581739
  43. 43

    Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.

    Smedfors G, Jennysdotter Olofsgård F, Steinberg A, et al.

    Brain sciences 2024; (14(4)) doi:10.3390/brainsci14040348.

    PMID: 38672000
  44. 44

    Recent advances in diagnosing, managing, and understanding the pathophysiology of cluster headache.

    Petersen AS, Lund N, Goadsby PJ, et al.

    The Lancet. Neurology 2024; (23(7)):712-724 doi:10.1016/S1474-4422(24)00143-1.

    PMID: 38876749
  45. 45

    Pre-cluster symptoms in a Taiwanese cohort of cluster headache: symptom profiles and clinical predictions.

    Wu JW, Chen ST, Wang YF, et al.

    The journal of headache and pain 2024; (25(1)):174 doi:10.1186/s10194-024-01862-8.

    PMID: 39379823
  46. 46

    Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review.

    Low ZXB, Yong SJ, Alrasheed HA, et al.

    Progress in neuro-psychopharmacology & biological psychiatry 2025; (137()):111279 doi:10.1016/j.pnpbp.2025.111279.

    PMID: 39909170
  47. 47

    Cluster headache diagnostic delay and its predictors: a systematic review with a meta-analysis.

    Van Obberghen EK, Fabre R, Lanteri-Minet M

    The journal of headache and pain 2025; (26(1)):71 doi:10.1186/s10194-025-02001-7.

    PMID: 40205372
  48. 48

    Sumatriptan-Induced Coronary Artery Vasospasm Leading to Acute ST Elevation Myocardial Infarction.

    Acharya R, Sapkota S, Ruck L, Abolbashari M

    Cureus 2025; (17(3)):e80920 doi:10.7759/cureus.80920.

    PMID: 40255801
  49. 49

    LSD's rapid antidepressant effects are modulated by 5-HT2B receptors.

    Bouloufa A, Delcourte S, Rovera R, et al.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025; (190()):118348 doi:10.1016/j.biopha.2025.118348.

    PMID: 40674920
  50. 50

    Chronic cluster headache is a rare disease: Implications for diagnosis, treatment and public health.

    Yuan H, Hoffmann J, Ruiz de la Torre E, et al.

    Cephalalgia : an international journal of headache 2025; (45(8)):3331024251369752 doi:10.1177/03331024251369752.

    PMID: 40836704
  51. 51

    Greater occipital nerve injection with methylprednisolone as transitional therapy in episodic cluster headache: Results from an RCT.

    Brandt RB, Mulleners WM, Couturier E, et al.

    Cephalalgia : an international journal of headache 2025; (45(9)):3331024251370324 doi:10.1177/03331024251370324.

    PMID: 40990636
  52. 52

    Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.

    Xu T, Wong S, Le GH, et al.

    Pharmacopsychiatry 2026; (59(2)):74-87 doi:10.1055/a-2794-6487.

    PMID: 41643722
  53. 53

    Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.

    Shiju S, Tirumala R, Marseille E

    Exploratory research in clinical and social pharmacy 2026; (21()):100709 doi:10.1016/j.rcsop.2026.100709.

    PMID: 41674667